Euro Gen MGF, 5mg

Euro-Gen

Peptides

Research peptide \u2013 Mechano Growth Factor (MGF)

Supplier states UK Based manufacturing with minimum peptide purity greater than 99% confirmed by third Party analytical testing.
Manufactured and distributed under a research Use Only framework; not authorised as a medicinal product under MHRA or EMA regulations.
Intended to comply with general laboratory chemical and research reagent standards, rather than medical device or medicinal product regulations.

Supplier states UK Based manufacturing with minimum peptide purity greater than 99% confirmed by third Party analytical testing.
Manufactured and distributed under a research Use Only framework; not authorised as a medicinal product under MHRA or EMA regulations.
Intended to comply with general laboratory chemical and research reagent standards, rather than medical device or medicinal product regulations.

Research peptide \u2013 Mechano Growth Factor (MGF)

Description

Euro-Gen MGF, 5mg is a UK-manufactured research-grade peptide containing Mechano Growth Factor (MGF), a splice variant of insulin-like growth factor-1 (IGF-1) associated in preclinical studies with skeletal muscle repair, tissue regeneration, and related cellular pathways. It is supplied as a 5 mg vial in the peptide category and is explicitly marketed for in vitro and laboratory research use only, not for human or veterinary administration.

Bnefits

Provides a defined research-grade source of Mechano Growth Factor (MGF), an IGF-1 splice variant implicated in muscle repair and tissue regeneration pathways in preclinical models.
Supplied as a 5 mg vial suitable for controlled laboratory experiments and in vitro mechanistic studies.
Produced under a UK-based brand that states minimum peptide purity >99% with third-party testing for composition and purity.
Offered with detailed storage guidance for lyophilised and reconstituted peptides to help maintain stability during research use.
Clearly labelled as a research-use-only reagent, helping to distinguish it from licensed medicinal products.

Indications

In vitro and laboratory research into Mechano Growth Factor (MGF) biology, including its role as an IGF-1 splice variant.
Preclinical research on skeletal muscle repair, regeneration, and satellite cell activation pathways.
Experimental studies on tissue repair, cartilage and bone biology, and neurobiological roles of MGF in non-clinical models.
Method development and assay validation involving MGF in cell culture, biochemical, or molecular biology experiments.
General educational and exploratory research on growth factor signalling, not involving administration to humans or animals.

Composition

Active component: Synthetic Mechano Growth Factor (MGF) peptide, 5 mg per vial (exact amino acid sequence and excipients not specified by the seller).

Formulation

Lyophilised (powder) peptide supplied for reconstitution prior to use in laboratory experiments.
Packaged as a 5 mg unit dose intended for in vitro and other non-clinical research applications.
No bacteriostatic water or diluent included; solvent must be supplied separately by the researcher.

Packaging

Single 5 mg research peptide unit (vial) listed under the Peptides category.
Sterile, sealed container suitable for cold-chain storage; detailed secondary packaging description not provided by the seller.
Sold individually via online peptide and aesthetic-product retailers.

Usage

For laboratory and in vitro research use only; not for human or veterinary use, injection, ingestion, or topical application.
Reconstitute the lyophilised peptide with an appropriate sterile solvent (e.g., bacteriostatic or sterile water for injection, as determined by institutional protocols) under aseptic conditions.
Mix gently after reconstitution and avoid excessive agitation that could denature the peptide.
Use reconstituted solutions promptly and store according to institutional peptide-handling SOPs; the seller does not provide dosage or administration guidance due to its research-only status.
Handle only by trained, qualified personnel in an appropriate laboratory environment, following local regulations and safety guidelines.
Dispose of any unused material and waste in accordance with institutional biosafety and chemical waste procedures.

Contraindications

Not to be used in humans or animals (no injection, ingestion, inhalation, or topical application).
Not indicated for therapeutic, cosmetic, or diagnostic use in any clinical setting.
Should not be used outside appropriately equipped research laboratories by untrained personnel.
Use is contraindicated in any context that would contravene local laws or regulations regarding unlicensed medicinal products or research chemicals.

Adverse Effects

No clinically characterised adverse-effect profile, as the product is not intended or licensed for administration to humans or animals.
Any potential toxicological or off-target effects must be evaluated within controlled experimental systems and must not be assumed to predict human safety.
Handling-related risks (e.g., accidental exposure, laboratory contamination) should be managed via standard laboratory safety protocols, including PPE use.

Storage Conditions

Lyophilised (powder) peptides should be stored at approximately -20°C to -80°C in a dry, dark environment for long-term stability.
After reconstitution, store at about 4°C and use within a few weeks as per institutional SOPs; avoid repeated freeze–thaw cycles.
Keep vials tightly capped, protected from light and moisture at all times.
Once the cap has been removed and the vial opened, immediate use is recommended and storage after opening is discouraged by the supplier.

Duration

Not applicable \u2013 Euro-Gen MGF, 5mg is a research-use-only peptide with no established or authorised clinical treatment duration.

Onset

Not applicable \u2013 no onset-of-effect data in humans; available information relates only to preclinical and in vitro models and must not be extrapolated to clinical use.